338857 <common-name>5-(1,3-benzodioxol-5-yl)-3-[[4-[[5-(1,3-benzodioxol-5-yl)-2-oxo-1,3,4-oxadiazol-3-yl]methyl]piperazin-1-yl]methyl]-1,3,4-oxadiazol-2-one</common-name> <description>5-(1,3-benzodioxol-5-yl)-3-[[4-[[5-(1,3-benzodioxol-5-yl)-2-oxo-1,3,4-oxadiazol-3-yl]methyl]piperazin-1-yl]methyl]-1,3,4-oxadiazol-2-one is a chemical compound with the formula C24H22N6O8. With an average molecular weight of 522.50 g/mol, 5-(1,3-benzodioxol-5-yl)-3-[[4-[[5-(1,3-benzodioxol-5-yl)-2-oxo-1,3,4-oxadiazol-3-yl]methyl]piperazin-1-yl]methyl]-1,3,4-oxadiazol-2-one is a heavy molecule.</description> <cas>73484-64-7</cas> <pubchem-id>3056180</pubchem-id> <chemical-formula>C24H22N6O8</chemical-formula> <weight>522.5</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T22:01:06Z</created-at> <updated-at type="dateTime">2026-08-30T22:01:06Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>C1CN(CCN1CN2C(=O)OC(=N2)C3=CC4=C(C=C3)OCO4)CN5C(=O)OC(=N5)C6=CC7=C(C=C6)OCO7</moldb-smiles> <moldb-formula>C24H22N6O8</moldb-formula> <moldb-inchi>InChI=1S/C24H22N6O8/c31-23-29(25-21(37-23)15-1-3-17-19(9-15)35-13-33-17)11-27-5-7-28(8-6-27)12-30-24(32)38-22(26-30)16-2-4-18-20(10-16)36-14-34-18/h1-4,9-10H,5-8,11-14H2</moldb-inchi> <moldb-inchikey>AGRJVNZYAIZXMC-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">522.1499117</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>2.7</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM334750</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>5-(1,3-benzodioxol-5-yl)-3-[[4-[[5-(1,3-benzodioxol-5-yl)-2-oxo-1,3,4-oxadiazol-3-yl]methyl]piperazin-1-yl]methyl]-1,3,4-oxadiazol-2-one</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Benzodioxoles</klass> <subklass nil="true"/> <paper-count type="integer" nil="true"/> <sync-id>CED0289283</sync-id> <structure-inchikey>AGRJVNZYAIZXMC-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>20800000000000000000028000000000000000000000000000000000000020000000000000002000000000000000400000000000000000000000000800000000000000000000000020800000000000000020002000000000000000000200000000800000100000800000020100000000000000000000000010010000000008000010000000000000800000000008000000000000000000000000000000000004000000080000000000000000000000008000000000000000000000000000000800000000010000001000000000000000000200000000010080000000100000010040000000400000000000080000000000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAmAAAALAAAAIABBgBgAAAAAgIGAGAAAAAC AgcAIAAAAAMGAGAAAAACAgYAYAAAAAICBwAgAAAAAwYAYAAAAAICB0AoAAAA AwMGQCgAAAADBAgAKAAAAAMCCEAoAAAAAwIGQCgAAAADBAdAKAAAAAMDBkAo AAAAAwQGQGgAAAADAwEGQCgAAAADBAZAKAAAAAMEBkBoAAAAAwMBBkBoAAAA AwMBCAAoAAAAAwIGAGAAAAACAggAKAAAAAMCBgBgAAAAAgIHQCgAAAADAwZA KAAAAAMECAAoAAAAAwIIQCgAAAADAgZAKAAAAAMEB0AoAAAAAwMGQCgAAAAD BAZAaAAAAAMDAQZAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEI ACgAAAADAgYAYAAAAAICCAAoAAAAAwILAAEAAQIAAgMAAwQABAUABQYABgcA BwhoDAgJKAIICmgMCgtoDAsMaAwLDSANDmgMDg9oDA8QaAwQEWgMERJoDBAT IBMUABQVAAIWABYXABcYaAwYGSgCGBpoDBobaAwbHGgMGx0gHR5oDB4faAwf IGgMICFoDCEiaAwgIyAjJAAkJQAFAAAMB2gMEg1oDBUPIBwXaAwiHWgMJR8g QgcAAAAGAAUEAwIBBQgHDAsKBg4PEBESDQUTEA8VFAUYFxwbGgYeHyAhIh0F IyAfJSQXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:39:30Z</structure-indexed-at> </compound>